ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet Technology Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13A17174
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Orally Disintegrating Tablet Technology Market Research Report 2024
BUY CHAPTERS

Global Orally Disintegrating Tablet Technology Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13A17174
Report
November 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
ROQUETTE
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF AG
Adare Pharma
Akina inc
Vitaquest

Orally Disintegrating Tablet Technology Market

The global Orally Disintegrating Tablet Technology market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Orally disintegrating tablet (ODT) technology involves the formulation of tablets that rapidly disintegrate and dissolve in the mouth without the need for water. This innovative pharmaceutical dosage form is designed to enhance patient convenience and compliance, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs typically utilize superdisintegrants, such as crospovidone or sodium starch glycolate, along with other excipients and processing techniques to promote rapid disintegration upon contact with saliva. The resulting tablet formulation provides a pleasant mouthfeel, quick dissolution, and improved bioavailability of the active pharmaceutical ingredient, making it suitable for various patient populations, including pediatric, geriatric, and psychiatric patients. Additionally, ODT technology offers advantages in terms of dosing accuracy, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Orally Disintegrating Tablet Technology leading manufacturers including Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, etc., dominate supply; the top five capture approximately % of global revenue, with Catalent leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Orally Disintegrating Tablet Technology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Orally Disintegrating Tablet Technology Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet Technology Market
Segment by Type
  • Lyophilization
  • Compressed Tablets
  • Cotton candy Process
Segment by Application
  • Pharmaceutical
  • Nutraceuticals
  • Chewable Vitamin
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, BASF, Adare Pharma, Akina, Vitaquest
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Orally Disintegrating Tablet Technology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Orally Disintegrating Tablet Technology Market report?

Ans: The main players in the Orally Disintegrating Tablet Technology Market are Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, BASF, Adare Pharma, Akina, Vitaquest

What are the Application segmentation covered in the Orally Disintegrating Tablet Technology Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet Technology Market report are Pharmaceutical, Nutraceuticals, Chewable Vitamin

What are the Type segmentation covered in the Orally Disintegrating Tablet Technology Market report?

Ans: The Types covered in the Orally Disintegrating Tablet Technology Market report are Lyophilization, Compressed Tablets, Cotton candy Process

1 Study Coverage
1.1 Introduction to Orally Disintegrating Tablet Technology: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Orally Disintegrating Tablet Technology Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lyophilization
1.2.3 Compressed Tablets
1.2.4 Cotton candy Process
1.3 Market Segmentation by Application
1.3.1 Global Orally Disintegrating Tablet Technology Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Nutraceuticals
1.3.4 Chewable Vitamin
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Technology Revenue Estimates and Forecasts 2020-2031
2.2 Global Orally Disintegrating Tablet Technology Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Orally Disintegrating Tablet Technology Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Orally Disintegrating Tablet Technology Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Lyophilization Market Size by Players
3.3.2 Compressed Tablets Market Size by Players
3.3.3 Cotton candy Process Market Size by Players
3.4 Global Orally Disintegrating Tablet Technology Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Orally Disintegrating Tablet Technology Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Orally Disintegrating Tablet Technology Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Orally Disintegrating Tablet Technology Market Size by Type (2020-2031)
6.4 North America Orally Disintegrating Tablet Technology Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Orally Disintegrating Tablet Technology Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Orally Disintegrating Tablet Technology Market Size by Type (2020-2031)
7.4 Europe Orally Disintegrating Tablet Technology Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Orally Disintegrating Tablet Technology Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Type (2020-2031)
8.4 Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Orally Disintegrating Tablet Technology Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Orally Disintegrating Tablet Technology Market Size by Type (2020-2031)
9.4 Central and South America Orally Disintegrating Tablet Technology Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Orally Disintegrating Tablet Technology Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Orally Disintegrating Tablet Technology Market Size by Type (2020-2031)
10.4 Middle East and Africa Orally Disintegrating Tablet Technology Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Orally Disintegrating Tablet Technology Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Business Overview
11.1.3 Catalent Orally Disintegrating Tablet Technology Product Features and Attributes
11.1.4 Catalent Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.1.5 Catalent Orally Disintegrating Tablet Technology Revenue by Product in 2024
11.1.6 Catalent Orally Disintegrating Tablet Technology Revenue by Application in 2024
11.1.7 Catalent Orally Disintegrating Tablet Technology Revenue by Geographic Area in 2024
11.1.8 Catalent Orally Disintegrating Tablet Technology SWOT Analysis
11.1.9 Catalent Recent Developments
11.2 SPI Pharma
11.2.1 SPI Pharma Corporation Information
11.2.2 SPI Pharma Business Overview
11.2.3 SPI Pharma Orally Disintegrating Tablet Technology Product Features and Attributes
11.2.4 SPI Pharma Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.2.5 SPI Pharma Orally Disintegrating Tablet Technology Revenue by Product in 2024
11.2.6 SPI Pharma Orally Disintegrating Tablet Technology Revenue by Application in 2024
11.2.7 SPI Pharma Orally Disintegrating Tablet Technology Revenue by Geographic Area in 2024
11.2.8 SPI Pharma Orally Disintegrating Tablet Technology SWOT Analysis
11.2.9 SPI Pharma Recent Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Corporation Information
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Product Features and Attributes
11.3.4 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.3.5 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Revenue by Product in 2024
11.3.6 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Revenue by Application in 2024
11.3.7 Takeda Pharmaceutical Orally Disintegrating Tablet Technology Revenue by Geographic Area in 2024
11.3.8 Takeda Pharmaceutical Orally Disintegrating Tablet Technology SWOT Analysis
11.3.9 Takeda Pharmaceutical Recent Developments
11.4 Fuisz Technologies
11.4.1 Fuisz Technologies Corporation Information
11.4.2 Fuisz Technologies Business Overview
11.4.3 Fuisz Technologies Orally Disintegrating Tablet Technology Product Features and Attributes
11.4.4 Fuisz Technologies Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.4.5 Fuisz Technologies Orally Disintegrating Tablet Technology Revenue by Product in 2024
11.4.6 Fuisz Technologies Orally Disintegrating Tablet Technology Revenue by Application in 2024
11.4.7 Fuisz Technologies Orally Disintegrating Tablet Technology Revenue by Geographic Area in 2024
11.4.8 Fuisz Technologies Orally Disintegrating Tablet Technology SWOT Analysis
11.4.9 Fuisz Technologies Recent Developments
11.5 Roquette
11.5.1 Roquette Corporation Information
11.5.2 Roquette Business Overview
11.5.3 Roquette Orally Disintegrating Tablet Technology Product Features and Attributes
11.5.4 Roquette Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.5.5 Roquette Orally Disintegrating Tablet Technology Revenue by Product in 2024
11.5.6 Roquette Orally Disintegrating Tablet Technology Revenue by Application in 2024
11.5.7 Roquette Orally Disintegrating Tablet Technology Revenue by Geographic Area in 2024
11.5.8 Roquette Orally Disintegrating Tablet Technology SWOT Analysis
11.5.9 Roquette Recent Developments
11.6 JRS Pharma
11.6.1 JRS Pharma Corporation Information
11.6.2 JRS Pharma Business Overview
11.6.3 JRS Pharma Orally Disintegrating Tablet Technology Product Features and Attributes
11.6.4 JRS Pharma Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.6.5 JRS Pharma Recent Developments
11.7 Fuji Chemical
11.7.1 Fuji Chemical Corporation Information
11.7.2 Fuji Chemical Business Overview
11.7.3 Fuji Chemical Orally Disintegrating Tablet Technology Product Features and Attributes
11.7.4 Fuji Chemical Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.7.5 Fuji Chemical Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Business Overview
11.8.3 Merck Orally Disintegrating Tablet Technology Product Features and Attributes
11.8.4 Merck Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.8.5 Merck Recent Developments
11.9 Galvita
11.9.1 Galvita Corporation Information
11.9.2 Galvita Business Overview
11.9.3 Galvita Orally Disintegrating Tablet Technology Product Features and Attributes
11.9.4 Galvita Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.9.5 Galvita Recent Developments
11.10 DAICEL
11.10.1 DAICEL Corporation Information
11.10.2 DAICEL Business Overview
11.10.3 DAICEL Orally Disintegrating Tablet Technology Product Features and Attributes
11.10.4 DAICEL Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BASF
11.11.1 BASF Corporation Information
11.11.2 BASF Business Overview
11.11.3 BASF Orally Disintegrating Tablet Technology Product Features and Attributes
11.11.4 BASF Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.11.5 BASF Recent Developments
11.12 Adare Pharma
11.12.1 Adare Pharma Corporation Information
11.12.2 Adare Pharma Business Overview
11.12.3 Adare Pharma Orally Disintegrating Tablet Technology Product Features and Attributes
11.12.4 Adare Pharma Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.12.5 Adare Pharma Recent Developments
11.13 Akina
11.13.1 Akina Corporation Information
11.13.2 Akina Business Overview
11.13.3 Akina Orally Disintegrating Tablet Technology Product Features and Attributes
11.13.4 Akina Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.13.5 Akina Recent Developments
11.14 Vitaquest
11.14.1 Vitaquest Corporation Information
11.14.2 Vitaquest Business Overview
11.14.3 Vitaquest Orally Disintegrating Tablet Technology Product Features and Attributes
11.14.4 Vitaquest Orally Disintegrating Tablet Technology Revenue and Gross Margin (2020-2025)
11.14.5 Vitaquest Recent Developments
12 Orally Disintegrating Tablet TechnologyIndustry Chain Analysis
12.1 Orally Disintegrating Tablet Technology Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Orally Disintegrating Tablet Technology Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Orally Disintegrating Tablet Technology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
ROQUETTE
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF AG
Adare Pharma
Akina inc
Vitaquest
List of Tables
 Table 1. Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Orally Disintegrating Tablet Technology Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Orally Disintegrating Tablet Technology Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Orally Disintegrating Tablet Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Orally Disintegrating Tablet Technology Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Orally Disintegrating Tablet Technology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Technology as of 2024)
 Table 11. Global Orally Disintegrating Tablet Technology Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Orally Disintegrating Tablet Technology Companies Headquarters
 Table 13. Global Orally Disintegrating Tablet Technology Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Orally Disintegrating Tablet Technology Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Orally Disintegrating Tablet Technology Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Orally Disintegrating Tablet Technology Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Orally Disintegrating Tablet Technology Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Orally Disintegrating Tablet Technology High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Orally Disintegrating Tablet Technology Growth Accelerators and Market Barriers
 Table 25. North America Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Orally Disintegrating Tablet Technology Growth Accelerators and Market Barriers
 Table 27. Europe Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Orally Disintegrating Tablet Technology Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Orally Disintegrating Tablet Technology Investment Opportunities and Key Challenges
 Table 31. Central and South America Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Orally Disintegrating Tablet Technology Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Orally Disintegrating Tablet Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Catalent Corporation Information
 Table 35. Catalent Description and Major Businesses
 Table 36. Catalent Product Features and Attributes
 Table 37. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Catalent Revenue Proportion by Product in 2024
 Table 39. Catalent Revenue Proportion by Application in 2024
 Table 40. Catalent Revenue Proportion by Geographic Area in 2024
 Table 41. Catalent Orally Disintegrating Tablet Technology SWOT Analysis
 Table 42. Catalent Recent Developments
 Table 43. SPI Pharma Corporation Information
 Table 44. SPI Pharma Description and Major Businesses
 Table 45. SPI Pharma Product Features and Attributes
 Table 46. SPI Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. SPI Pharma Revenue Proportion by Product in 2024
 Table 48. SPI Pharma Revenue Proportion by Application in 2024
 Table 49. SPI Pharma Revenue Proportion by Geographic Area in 2024
 Table 50. SPI Pharma Orally Disintegrating Tablet Technology SWOT Analysis
 Table 51. SPI Pharma Recent Developments
 Table 52. Takeda Pharmaceutical Corporation Information
 Table 53. Takeda Pharmaceutical Description and Major Businesses
 Table 54. Takeda Pharmaceutical Product Features and Attributes
 Table 55. Takeda Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Takeda Pharmaceutical Revenue Proportion by Product in 2024
 Table 57. Takeda Pharmaceutical Revenue Proportion by Application in 2024
 Table 58. Takeda Pharmaceutical Revenue Proportion by Geographic Area in 2024
 Table 59. Takeda Pharmaceutical Orally Disintegrating Tablet Technology SWOT Analysis
 Table 60. Takeda Pharmaceutical Recent Developments
 Table 61. Fuisz Technologies Corporation Information
 Table 62. Fuisz Technologies Description and Major Businesses
 Table 63. Fuisz Technologies Product Features and Attributes
 Table 64. Fuisz Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Fuisz Technologies Revenue Proportion by Product in 2024
 Table 66. Fuisz Technologies Revenue Proportion by Application in 2024
 Table 67. Fuisz Technologies Revenue Proportion by Geographic Area in 2024
 Table 68. Fuisz Technologies Orally Disintegrating Tablet Technology SWOT Analysis
 Table 69. Fuisz Technologies Recent Developments
 Table 70. Roquette Corporation Information
 Table 71. Roquette Description and Major Businesses
 Table 72. Roquette Product Features and Attributes
 Table 73. Roquette Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Roquette Revenue Proportion by Product in 2024
 Table 75. Roquette Revenue Proportion by Application in 2024
 Table 76. Roquette Revenue Proportion by Geographic Area in 2024
 Table 77. Roquette Orally Disintegrating Tablet Technology SWOT Analysis
 Table 78. Roquette Recent Developments
 Table 79. JRS Pharma Corporation Information
 Table 80. JRS Pharma Description and Major Businesses
 Table 81. JRS Pharma Product Features and Attributes
 Table 82. JRS Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. JRS Pharma Recent Developments
 Table 84. Fuji Chemical Corporation Information
 Table 85. Fuji Chemical Description and Major Businesses
 Table 86. Fuji Chemical Product Features and Attributes
 Table 87. Fuji Chemical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Fuji Chemical Recent Developments
 Table 89. Merck Corporation Information
 Table 90. Merck Description and Major Businesses
 Table 91. Merck Product Features and Attributes
 Table 92. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Merck Recent Developments
 Table 94. Galvita Corporation Information
 Table 95. Galvita Description and Major Businesses
 Table 96. Galvita Product Features and Attributes
 Table 97. Galvita Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Galvita Recent Developments
 Table 99. DAICEL Corporation Information
 Table 100. DAICEL Description and Major Businesses
 Table 101. DAICEL Product Features and Attributes
 Table 102. DAICEL Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. DAICEL Recent Developments
 Table 104. BASF Corporation Information
 Table 105. BASF Description and Major Businesses
 Table 106. BASF Product Features and Attributes
 Table 107. BASF Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. BASF Recent Developments
 Table 109. Adare Pharma Corporation Information
 Table 110. Adare Pharma Description and Major Businesses
 Table 111. Adare Pharma Product Features and Attributes
 Table 112. Adare Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Adare Pharma Recent Developments
 Table 114. Akina Corporation Information
 Table 115. Akina Description and Major Businesses
 Table 116. Akina Product Features and Attributes
 Table 117. Akina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Akina Recent Developments
 Table 119. Vitaquest Corporation Information
 Table 120. Vitaquest Description and Major Businesses
 Table 121. Vitaquest Product Features and Attributes
 Table 122. Vitaquest Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Vitaquest Recent Developments
 Table 124. Raw Materials Key Suppliers
 Table 125. Distributors List
 Table 126. Market Trends and Market Evolution
 Table 127. Market Drivers and Opportunities
 Table 128. Market Challenges, Risks, and Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources


List of Figures
 Figure 1. Orally Disintegrating Tablet Technology Product Picture
 Figure 2. Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Lyophilization Product Picture
 Figure 4. Compressed Tablets Product Picture
 Figure 5. Cotton candy Process Product Picture
 Figure 6. Global Orally Disintegrating Tablet Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pharmaceutical
 Figure 8. Nutraceuticals
 Figure 9. Chewable Vitamin
 Figure 10. Orally Disintegrating Tablet Technology Report Years Considered
 Figure 11. Global Orally Disintegrating Tablet Technology Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Orally Disintegrating Tablet Technology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Orally Disintegrating Tablet Technology Revenue Market Share by Region (2020-2031)
 Figure 15. Global Orally Disintegrating Tablet Technology Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Lyophilization Revenue Market Share by Player in 2024
 Figure 18. Compressed Tablets Revenue Market Share by Player in 2024
 Figure 19. Cotton candy Process Revenue Market Share by Player in 2024
 Figure 20. Global Orally Disintegrating Tablet Technology Revenue Market Share by Type (2020-2031)
 Figure 21. Global Orally Disintegrating Tablet Technology Revenue Market Share by Application (2020-2031)
 Figure 22. North America Orally Disintegrating Tablet Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Orally Disintegrating Tablet Technology Revenue (US$ Million) in 2024
 Figure 24. North America Orally Disintegrating Tablet Technology Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Orally Disintegrating Tablet Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Orally Disintegrating Tablet Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Orally Disintegrating Tablet Technology Revenue (US$ Million) in 2024
 Figure 31. Europe Orally Disintegrating Tablet Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Orally Disintegrating Tablet Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 34. France Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Orally Disintegrating Tablet Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Orally Disintegrating Tablet Technology Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Orally Disintegrating Tablet Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Orally Disintegrating Tablet Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 46. India Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Orally Disintegrating Tablet Technology Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Orally Disintegrating Tablet Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Orally Disintegrating Tablet Technology Revenue (US$ Million) in 2024
 Figure 54. Central and South America Orally Disintegrating Tablet Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Orally Disintegrating Tablet Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Orally Disintegrating Tablet Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Orally Disintegrating Tablet Technology Revenue (US$ Million) in 2024
 Figure 60. South America Orally Disintegrating Tablet Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Orally Disintegrating Tablet Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Orally Disintegrating Tablet Technology Revenue (2020-2025) & (US$ Million)
 Figure 66. Orally Disintegrating Tablet Technology Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024
Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024
Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030
Global Orally Disintegrating Tablets Market Research Report 2024
Orally Disintegrating Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orally Disintegrating Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fast disintegrating Tablets Market Insights Forecast to 2030
Global Mouth dissolving Tablets Market Insights Forecast to 2030
Global Rapid dissolving Tablets Market Insights Forecast to 2030
Global Fast dissolving Tablets Market Insights Forecast to 2030
Global Oral Disintegrating Strips Market Research Report 2024
Global Orodispersible Tablets Market Insights Forecast to 2030
Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024
Global Orally Disintegrating Films ODFs Market Research Report 2025
Global Orally Fast Dissolving Films OFDFs Market Research Report 2025
Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025
Global Fast Melt Tablet Market Research Report 2024
Global Orodispersible Film Market Research Report 2025
Global Orally Disintegrating Granules ODGs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions